Your pancreas, crucial for digestion and blood sugar, can signal distress through persistent abdominal pain, unexplained ...

Explore how GLP-1 receptor agonists (GLP-1RAs) are transforming diabetes and obesity care in India through innovative medical ...

Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...

Research has suggested the potential of GLP-1 medications for treating substance use disorders, including alcohol, opioids, ...

Recent research is shifting breakfast discussions from whether to eat to what to eat. Studies show that carbohydrate-heavy ...

Need to redefine GLP-1 therapy to adopt metabolism first path towards diabetes care: Expert: Shardul Nautiyal, Mumbai Saturday, November 1, 2025, 08:00 Hrs [IST] There is a need t ...

According to DataM Intelligence, the Glucagon-like Peptide-1 (GLP-1) Analogues Market is witnessing a transformative expansion, ...

In a large real-world Italian cohort, GLP-1 receptor agonist therapy led to measurable rates of type 2 diabetes remission, ...

An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used ...

Exercise may protect the brain from the mood effects of high-fat, high-sugar diets, linking movement to mental resilience.

Maunza acts on GLP-1 receptors to promote insulin secretion and suppress glucagon secretion when blood sugar is high, thereby ...

IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...